SecBot SecBot
144 ·Filed Aug 20, 2026

ARDT

Ardent Health, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed2mo ago SEC0001959173-26-006282
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine post-employment sale by a former insider of shares received as compensation. No material read-through for the stock. Monitor for any additional insider filings, but this single Form 144 does not warrant a trading response.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
ARDT ▼ -3.46% at T+20d
NEUTRAL call -3.46% · α vs SPY -2.93% · entry $10.99 → $10.61
Next anchor: T+60d in 16d
Latest observation: T+45 +13.58% FF3 residual α
Entry = T+0 close
Aug 20, 2026
via day close
T+1d
+2.37%
call +2.37% · α +2.66%
$11.25
settled 2mo ago
T+5d
-0.27%
call -0.27% · α -0.75%
$10.96
settled 2mo ago
T+20d
-3.46%
call -3.46% · α -2.93%
$10.61
settled 6w ago
T+60d
Pending
in 16d

Price Chart

Loading chart...

Executive Summary

Martin Bonick, a former officer and director of Ardent Health, filed a Form 144 notice of intent to sell 35,930 shares of common stock, with an approximate market value of $393,482 based on the August 18, 2026 trade date. This is a routine post-departure sale of shares acquired through restricted stock vesting and compensation, and does not signal any new material concern about the company's operations or outlook.

Key Facts

  • Martin Bonick, a former officer and director, filed a Form 144 to sell 35,930 shares of Ardent Health common stock.
  • The approximate market value of the proposed sale is $393,481.70 based on the August 18, 2026 trade date.
  • The shares were acquired through restricted stock vesting on March 31, 2026 (8,994 shares) and April 1, 2026 (26,936 shares), both as compensation.
  • The sale is being handled through Fidelity Brokerage Services LLC.

Financial Impact

Proposed sale of 35,930 shares valued at approximately $393,482, representing a small fraction of the company's $1.5B market cap.

dilution

Risk Factors

  • If additional insiders file Form 144s in the coming weeks, it could signal broader insider sentiment.
  • The sale is an intent to sell; it may or may not be executed.

Market Snapshot

Exchange
NYSE
Sector
Services-General Medical & Surgical Hospitals, NEC
Analyst Consensus
67% bullish (18 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-006282
Document: 0001959173-26-006282-index.html0001959173-26-006282
Document: 0001959173-26-006282.txt0001959173-26-006282
9 reports for ARDT
Performance horizon
67% Hit rate @ T+1 2 of 3 directional calls Went positive at some point 3 of 3 best @ T+60▲ +13.87%May 5, 2026
Filters
Rows
Reports for ARDT — sortable, filterable
TypeNow
Oct 23, 2026
4d ago
8-K
BEARISH ★ 5/10
$12.18 $11.83▲ +2.87%▲ +3.43%$12.18 (−0.00%)
Aug 20, 2026
9w ago
144
NEUTRAL ★ 2/10
$10.99 $11.25▲ +2.37%▲ +2.66%$12.18 (+10.83%)
Aug 15, 2026
10w ago
Institutional Cluster
BULLISH ★ 5/10
$10.89 $10.93▲ +0.37%▲ +1.04%$12.18 (+11.85%)
Jun 30, 2026
17w ago
8-K
NEUTRAL ★ 3/10
$10.13 $10.76▲ +6.22%▲ +6.35%$12.18 (+20.24%)
Jun 11, 2026
19w ago
Institutional Cluster
NEUTRAL ★ 3/10
$9.67 $9.35▼ −3.31%▼ −3.85%$12.18 (+25.96%)
Jun 2, 2026
21w ago
8-K
MIXED ★ 5/10
$7.83 $8.60▲ +9.83%▲ +9.43%$12.18 (+55.56%)
May 5, 2026
25w ago
8-K
BULLISH ★ 6/10
$9.37 $9.37· 0.00%▲ +0.33%$12.18 (+29.99%)
Apr 8, 2026
28w ago
DEFA14A
NEUTRAL ★ 2/10
$9.53 $9.40▼ −1.36%▼ −1.30%$12.18 (+27.81%)
Mar 4, 2026
33w ago
8-K
MIXED ★ 6/10
$9.44 $8.90▼ −5.72%▼ −4.41%$12.18 (+29.03%)
Showing 9 of 9

US Market Status

Market Closed — Opens Thu (13h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 20, 2026